Cargando…

Identifying a molecular profile to predict the risk of recurrence in high‐intermediate risk endometrial cancer

BACKGROUND: Patients with high‐intermediate risk endometrial cancer (H‐IR EMCA) have an elevated risk of recurrence compared to low‐risk counterparts. Many H‐IR EMCA patients are treated with radiation or chemotherapy, but their overall survival is not significantly impacted by treatment. The object...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arend, Rebecca C., Scalise, Carly B., Dholakia, Jhalak, Kamal, Maahum Z., Thigpen, Haley B., Crossman, David, Huh, Warner K., Leath, Charles A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Bioinfomatics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607249/ https://www.ncbi.nlm.nih.gov/pubmed/34729947 http://dx.doi.org/10.1002/cam4.4247

Ejemplares similares

Artificial intelligence in oncology: Path to implementation
por: Chua, Isaac S., et al.
Publicado: (2021)

Prognostic value of CCR2 as an immune indicator in lung adenocarcinoma: A study based on tumor‐infiltrating immune cell analysis
por: Wan, Yi, et al.
Publicado: (2021)

Development and validation of MRI‐based deep learning models for prediction of microsatellite instability in rectal cancer
por: Zhang, Wei, et al.
Publicado: (2021)

A construction and comprehensive analysis of ceRNA networks and infiltrating immune cells in papillary renal cell carcinoma
por: Fan, Yaqi, et al.
Publicado: (2021)

Construction of circRNA‐based ceRNA network and its prognosis‐associated subnet of clear cell renal cell carcinoma
por: Zhang, Yuwei, et al.
Publicado: (2021)

Identification of a glycolysis‐related gene signature for survival prediction of ovarian cancer patients
por: Zhang, Dai, et al.
Publicado: (2021)

A novel five‐gene signature predicts overall survival of patients with hepatocellular carcinoma
por: Wang, Zhigang, et al.
Publicado: (2021)

Data mining of an acoustic biomarker in tongue cancers and its clinical validation
por: Xiao, Yudong, et al.
Publicado: (2021)

Identification of inhibitory immune checkpoints and relevant regulatory pathways in breast cancer stem cells
por: Shi, Haojun, et al.
Publicado: (2021)

Assessing Preclinical Research Models for Immunotherapy for Gynecologic Malignancies
por: Dholakia, Jhalak, et al.
Publicado: (2021)

A 4-Gene Signature Associated With Recurrence in Low- and Intermediate-Risk Endometrial Cancer
por: de Andrade, Diocésio Alves Pinto, et al.
Publicado: (2021)

Laparoscopic surgery for low, intermediate and high-risk endometrial cancer
por: Vardar, Mehmet Ali, et al.
Publicado: (2018)

Gynecologic oncology patients are ready for telemedicine in routine care: Results from a pre-COVID survey
por: Dholakia, J., et al.
Publicado: (2021)

The impact of Ki-67 index, squamous differentiation, and several clinicopathologic parameters on the recurrence of low and intermediate-risk endometrial cancer
por: Ocak, Birol, et al.
Publicado: (2021)

Assessing recurrence risk following intraperitoneal chemotherapy for ovarian cancer: A day late and a dollar short?
por: Leath, Charles A., et al.
Publicado: (2019)

The baseline recurrence risk of patients with intermediate-risk cervical cancer
por: Yoneoka, Yutaka, et al.
Publicado: (2021)

The Role of Para-Aortic Lymphadenectomy in the Surgical Staging of Women with Intermediate and High-Risk Endometrial Adenocarcinomas
por: May, Taymaa, et al.
Publicado: (2013)

Role of lymphadenectomy in intermediate-risk endometrial cancer: a matched-pair study
por: Coronado, Pluvio J., et al.
Publicado: (2018)

Identity-related experiences of Asian American trainees in gynecologic oncology
por: Dholakia, Jhalak, et al.
Publicado: (2022)

Impact of vaginal brachytherapy in intermediate and high-intermediate risk endometrial cancer: a multicenter study from the FRANCOGYN group
por: Reboux, Pierre-Alain, et al.
Publicado: (2019)

Risk factors for recurrence amongst high intermediate risk patients with endometrioid adenocarcinoma
por: Bahng, Agnes Y., et al.
Publicado: (2012)

Systematic lymphadenectomy for intermediate risk endometrial carcinoma treatment does not improve the oncological outcome
por: Candido, Elaine C., et al.
Publicado: (2019)

Squamous differentiation portends poor prognosis in low and intermediate-risk endometrioid endometrial cancer
por: de Andrade, Diocesio Alves Pinto, et al.
Publicado: (2019)

Role of systematic lymphadenectomy in patients with intermediate to high-risk early stage endometrial cancer
por: Kim, Nae Ry, et al.
Publicado: (2022)

Prehabilitation for medically frail patients undergoing surgery for epithelial ovarian cancer: a cost-effectiveness analysis
por: Dholakia, Jhalak, et al.
Publicado: (2021)

Baseline risk of recurrence in stage I–II endometrial carcinoma
por: Sasada, Shinsuke, et al.
Publicado: (2018)

One-week vaginal brachytherapy schedule as exclusive adjuvant post-operative treatment in intermediate- and high-intermediate-risk endometrial cancer patients
por: De Sanctis, Vitaliana, et al.
Publicado: (2020)

Improving locoregional outcome in high-intermediate-risk and high-risk stage I endometrial cancer with surgical staging followed by brachytherapy
por: Abakay, Candan Demiroz, et al.
Publicado: (2022)

Avoiding Full Lymphadenectomies in Intermediate- and High-Risk Endometrial Cancer by Sentinel Lymph Node Biopsy Implementation
por: Pineda, Virginia García, et al.
Publicado: (2021)

Endometrial hyperplasia as a risk factor of endometrial cancer
por: Nees, Lisa K., et al.
Publicado: (2022)

Recurrence risk factors in stage IA grade 1 endometrial cancer
por: Nwachukwu, Chika, et al.
Publicado: (2021)

Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy
por: Wortman, B. G., et al.
Publicado: (2018)

AMIGO2 expression as a predictor of recurrence in cervical cancer with intermediate risk
por: Iida, Yuki, et al.
Publicado: (2023)

The “Sandwich” Schedule: A Well-Tolerated Adjuvant Treatment Both in Intermediate–High- and High-Risk Endometrial Cancer
por: Ferrero, Annamaria, et al.
Publicado: (2022)

Stratification of risk groups according to survival after recurrence in endometrial cancer patients
por: Shim, Seung-Hyuk, et al.
Publicado: (2017)

Serum Proteomic Profiles of Patients with High and Low Risk of Endometrial Cancer Recurrence
por: Pietkiewicz, Dagmara, et al.
Publicado: (2023)

Utilization of a 3-D tissue engineered model to investigate the effects of perfusion on gynecologic cancer biology
por: Martinez, Alba, et al.
Publicado: (2021)

Open Surgery including Lymphadenectomy without Adjuvant Therapy for Uterine-Confined Intermediate- and High-Risk Endometrioid Endometrial Carcinoma
por: Otsuka, Isao, et al.
Publicado: (2022)

Molecular profile-based recommendations for postoperative adjuvant therapy in early endometrial cancer with high-intermediate or intermediate risk: a Chinese randomized phase III trial (PROBEAT)
por: Li, Yang, et al.
Publicado: (2023)

Transcriptomic recurrence score improves recurrence prediction for surgically treated patients with intermediate‐risk clear cell kidney cancer
por: Patel, Neal, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_91i72v2v17kcsi65g9ovm0up4v